Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer

NCT01106066 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01106066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01106066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer
Lead sponsor
Samsung Medical Center
Phase
Phase 1/2
Overall status
Terminated
Start date
March 31, 2009
Completion date
November 30, 2012
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

phase i: to determine the maximum tolerated dose (mtd), phase ii: to assess the pathologic cr rate and feasibility following neoadjuvant chemoradiation therapy with s1/oxaliplatin